FTXHvsPJPETF Comparison
VS
First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Invesco Dynamic Pharmaceuticals ETF (PJP) belong to the same industry segment: US Health Care. Both ETFs have the same top 1 sector exposures: Healthcare. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.58% for PJP. FTXH is up 23.32% year-to-date (YTD) with +$978M in YTD flows. PJP performs worse with 19.39% YTD performance, and +$167M in YTD flows. Run a side-by-side ETF comparison of FTXH and PJP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FTXH vs PJP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH PJP | +0.75%-0.51% | +14.81%+9.32% | +23.32%+19.39% | +46.70%+33.82% | +58.20%+66.43% | +66.91%+64.80% |
| Flows | FTXH PJP | +$41M+$44M | +$968M+$157M | +$978M+$167M | +$981M+$182M | +$973M+$114M | +$977M-$32M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH PJP | +20.07%+18.13% | +17.74%+17.16% | +16.99%+16.34% | +16.34%+16.47% |
| Max drawdown | FTXH PJP | -5.34%-5.67% | -7.50%-9.42% | -19.32%-16.11% | -19.32%-17.41% |
| Max drawdown duration | FTXH PJP | 16d23d | 99d108d | 393d275d | 393d788d |
Trading data
FTXH | PJP | |
Last sale 9/11/2026 at 1:30 PM | $40.47 | $124.09 |
| Previous close 09/10/2026 | $40.52 | $124.74 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FTXH | PJP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
FTXH | PJP | |
|---|---|---|
| Last price | $40.47 | $124.09 |
| 1D performance | -0.13% | -0.52% |
| AuM | $1.04 B | $544.86 M |
| E/R | 0.6% | 0.58% |
Characteristics
FTXH | PJP | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | Invesco |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | Dynamic Pharmaceutical Intellidex Index |
| N° of holdings | 49 | 28 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | June 23, 2005 |
| ESG | No | No |
Advertisement
Exposure
Countries
FTXH
USA
95.79%
Other
4.21%
PJP
USA
94.69%
Other
5.31%
Sectors
FTXH
Healthcare
99.86%
Other
0.14%
PJP
Healthcare
100%
Other
-0%
Diversification
FTXH
Total weight of top 15 holdings out of 15
66.98%
PJP
Total weight of top 15 holdings out of 15
65.5%
Top 15 holdings
Data as of July 31, 2026
FTXH
Merck & Co., Inc.
7.58%
Eli Lilly & Co.
7.43%
AbbVie, Inc.
7.11%
Johnson & Johnson
6.78%
Bristol Myers Squibb Co.
6.61%
Amgen, Inc.
3.53%
Biogen, Inc.
3.52%
Vertex Pharmaceuticals, Inc.
3.43%
Viatris, Inc.
3.40%
Regeneron Pharmaceuticals, Inc.
3.34%
Pfizer Inc.
3.17%
Cardinal Health, Inc.
3.14%
Gilead Sciences, Inc.
3.03%
Incyte Corp.
2.48%
United Therapeutics Corp.
2.43%
PJP
Abbott Laboratories
5.76%
AbbVie, Inc.
5.71%
Amgen, Inc.
5.33%
Johnson & Johnson
5.33%
Eli Lilly & Co.
5.25%
Merck & Co., Inc.
5.03%
Gilead Sciences, Inc.
4.58%
Pfizer Inc.
4.49%
Corcept Therapeutics, Inc.
4.00%
Amneal Pharmaceuticals, Inc.
3.88%
Liquidia Corp.
3.75%
Travere Therapeutics, Inc.
3.26%
Ligand Pharmaceuticals, Inc.
3.18%
Harmony Biosciences Holdings, Inc.
3.10%
Viatris, Inc.
2.85%
Frequently asked questions about FTXH and PJP
How have the FTXH and PJP ETFs performed in 2026?
As of September 10, 2026, FTXH is up 23.32% year-to-date (YTD), while PJP has returned 19.39%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: FTXH or PJP?
Year-to-date, the FTXH ETF saw +$978M in flows, compared to +$167M for PJP.
Which ETF is more volatile: FTXH or PJP?
Over the past year, FTXH had a volatility of 17.74%, while PJP experienced 17.16%.
Which ETF is bigger: FTXH or PJP?
As of September 10, 2026, FTXH holds $1.04 B in assets under management (AUM), while PJP manages $544.86 M.
What sectors do the FTXH and PJP ETFs invest in?
FTXH leans toward sectors like Healthcare. Meanwhile, PJP focuses on Healthcare.
What are the top holdings of the FTXH ETF and PJP ETF?
FTXH top holdings include Merck & Co., Inc., Eli Lilly & Co. and AbbVie, Inc.. PJP holds in its top three: Abbott Laboratories, AbbVie, Inc. and Amgen, Inc..
Which ETF is more diversified: FTXH or PJP?
FTXH holds 49 securities with 66.98% of its assets in the top 15. PJP has 28 securities and a top 15 weight of 65.5%.
Advertisement
Advertisement
